All companies
Visit website
COVINNOVATIONS™
OperatingCovInnovations Inc
Healthcare · Technology · Founded 2021
The new standard of covid-19 solutions
Post-money valuation ⓘ
$50.0M
As of Feb 2023 · from CovInnovations Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$4,297
Across 1 round since 2022
Latest share price
$7.40
CovInnovations Common Stock 1 offering price
Financials
FY2020–FY2021 · from SEC filings · hover any figure for its source$0
2020
$0
−$832K
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
-$831,753
Taxes paid
$0
$0
Balance sheet
Cash
$0
$2,127
Accounts receivable
$0
$72,348
Total assets
$0
$74,476
Short-term debt
$0
$296,233
Long-term debt
$0
$609,996
Total liabilities
$0
$906,229
Other
Headcount
—
3
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$50.0M
post-money
CovInnovations Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $4.3K / $1.2MInvestors 8Post-money $50M
Reg CF annual-report compliance
Not obligated
never closed a Reg CF raise
8 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001954285Share price $7.40
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.